Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
MarketWatch· Jules Rimmer· Sep 30, 2026 · 11:12 AM
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
markets14 minutes ago
U.S. inflation rises again and keeps the pressure on Fed
The main inflation gauge used by the Federal Reserve to set U.S. interest rates rose sharply in August, underscoring why the central bank raised interest rates earlier this month for the first time in three years.
MarketWatch
markets21 minutes ago
Meta is pitching a bold new identity — and the payoff could be big
Enterprise tools present a compelling business opportunity as Facebook and Instagram parent Meta looks to diversify its revenue away from advertising.
MarketWatch
marketsabout 1 hour ago
‘I’m afraid of human stupidity’: Why this top economist prefers U.S. tech and gold over bonds
A prominent economist doesn’t fear artificial intelligence, but fully embraces it in portfolios. He feels far differently about government debt.
MarketWatch